Large Between-Patient Variability in eGFR Decline before Clinical Trial Enrollment and Impact on Atrasentan?s Efficacy: A Post Hoc Analysis from the SONAR Trial
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY(2021)
摘要
n/a.
更多查看译文
关键词
eGFR decline, type 2 diabetes, endothelin receptor antagonist, chronic kidney disease, randomized controlled trials
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要